Since January, InCrowd has been conducting novel coronavirus (COVID-19) tracking research to understand the impact of the pandemic on several US healthcare stakeholder groups. Now in its fifth wave, InCrowd has been monitoring frontline-treating physicians’ perceptions on the spread of the virus, preparedness, a variety of concerns, and how they envision both pharma engagement and care delivery in the future. Discover the latest findings and insights from InCrowd’s most recent wave of COVID-19 physician research.

Methodology:

• Method: 12-minute MicroSurvey via InCrowd
• Crowds: US Primary Care Physicians (PCPs), Pediatricians (PEDs), and Emergency Medicine or Critical Care Physicians (EMCCs)
• Sample Size: n=211
• Fielding Period: June 26, 2020 (Previous Waves: May 29-31, Apr. 14-15, Mar. 19-20, Feb. 26-27, Jan. 31-Feb. 4)

InCrowd’s other COVID-19 Tracking Reports:

• Patient Tracking Report—Wave 3
• COVID-19 Vaccine Development Report
• Non-Frontline Specialist Tracking Report – Wave 2
• Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic
• Telemedicine & Remote-Patient Monitoring Report
•